There's been much talk of how US health reform will impact physicians, patients, and insurance companies. But how will it affect the often overlooked specialty drug market?
John Swen
Advertisement
Articles by John Swen
Advertisement
Latest Updated Articles
- Specialty Care Medicines: Managing the Impact of US Health Reform
November 1st 2010
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
2
The Evolving Relationship Between FDA and Biotech
3
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
4
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
5